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RESEARCH
Regeneration of a neoartery 
through a completely autologous acellular 
conduit in a minipig model: a pilot study
Tao Wang1,7†, Nianguo Dong1†, Huimin Yan1, Sze Yue Wong2,3, Wen Zhao2,4, Kang Xu1, Dong Wang2,5, 
Song Li2,5,6 and Xuefeng Qiu1,2,5*
Abstract 
Background: Vascular grafts are widely used as a treatment in coronary artery bypass surgery, hemodialysis, periph-
eral arterial bypass and congenital heart disease. Various types of synthetic and natural materials were experimented 
to produce tissue engineering vascular grafts. In this study, we investigated in vivo tissue engineering technology in 
miniature pigs to prepare decellularized autologous extracellular matrix-based grafts that could be used as vascular 
grafts for small-diameter vascular bypass surgery.
Methods: Autologous tissue conduits (3.9 mm in diameter) were fabricated by embedding Teflon tubings in the sub-
cutaneous pocket of female miniature pigs (n = 8, body weight 25–30 kg) for 4 weeks. They were then decellularized 
by CHAPS decellularization solution. Heparin was covalently-linked to decellularized tissue conduits by Sulfo-NHS/
EDC. We implanted these decellularized, completely autologous extracellular matrix-based grafts into the carotid 
arteries of miniature pigs, then sacrificed the pigs at 1 or 2 months after implantation and evaluated the patency rate 
and explants histologically.
Results: After 1 month, the patency rate was 100% (5/5) while the inner diameter of the grafts was 3.43 ± 0.05 mm 
(n = 5). After 2 months, the patency rate was 67% (2/3) while the inner diameter of the grafts was 2.32 ± 0.14 mm 
(n = 3). Histological staining confirmed successful cell infiltration, and collagen and elastin deposition in 2-month 
samples. A monolayer of endothelial cells was observed along the inner lumen while smooth muscle cells were domi-
nant in the graft wall.
Conclusion: A completely autologous acellular conduit with excellent performance in mechanical properties can be 
remodeled into a neoartery in a minipig model. This proof-of-concept study in the large animal model is very encour-
aging and indicates that this is a highly feasible idea worthy of further study in non-human primates before clinical 
translation.
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Background
Ischaemic heart disease became the leading cause of 
death around the world, vascular bypass surgery remains 
the primary treatment for patients with ischaemic heart 
disease [1], as well as being widely used in lower extrem-
ity bypass [2]. Autologous vessels such as saphenous 
veins and internal mammary arteries are the gold-stand-
ard grafts used as vascular prosthesis. Unfortunately, 
these vessels are not always available or suitable for surgi-
cal procedure due to former bypass surgery or pre-exist-
ing vascular disease [3–5].
When autologous vessels are not available, other arti 
Figure cial grafts are often used. Dacron and polytetra-
fluoroethylene (PTFE) are two synthetic materials that 
are widely used for large-diameter (≥ 6 mm) grafts, such 
as arteriovenous access for hemodialysis, peripheral 
arterial bypass above the knee [6]. Unfortunately, these 
synthetic materials have failed when used for small-
diameter (< 6 mm) grafts due to infection, thrombus for-
mation or intimal hyperplasia [7]. Over the past three 
decades, tissue engineering vascular grafts (TEVGs) 
were widely studied to explore grafts which were immu-
nologically compatible, nonthrombogenic and can grow 
and be remolded. Numerous TEVGs such as cell seeded 
synthetic grafts, collagen and fibrin-based vessels, cell 
self-assembly vessels and biodegradable synthetic poly-
mer scaffolds have been developed. However, immune 
response, thrombus formation, intimal hyperplasia, low 
mechanical strength and a complicated processing pro-
cedure limit their clinical applications [8–12].
A novel method to fabricate TEVGs utilizing in  vivo 
tissue engineering technology was first proposed by 
Sparks et  al. [13]. Briefly, a rod was inserted under the 
skin and, over a period of time, the granulation tis-
sue was formed. The rod was then removed leaving the 
autologous tissue conduit which can be used as a vascu-
lar graft. This kind of grafts can be easily obtained and 
were immune-free to the host, but they failed due to poor 
burst strength and low patency rate. Following this, both 
Campbell and Nakayama proposed modifications to the 
process. Campbell et al. employed a silastic tube as a rod 
to be inserted and everted the tissue capsule to ensure 
the inner wall was covered with non-thrombotic meso-
thelial cells [14]. Meanwhile, Nakayama et al. adopted sil-
icone rods and coated the tissue capsule with argatroban 
[15]. Although advances were made, the complications 
and unsatisfactory patency rate caused by relatively poor 
mechanical properties, thrombus formation and intimal 
hyperplasia make them inappropriate for clinical use. 
Niklason et  al. and Tedd et  al. engineered the decellu-
larized extracellular matrix vascular grafts using human 
allogeneic or autologous cells for chronic haemodialysis. 
Therefore, this research seeks to describe the methods to 
develop decellularized completely autologous extracel-
lular matrix-based grafts with appropriate mechanical 
properties and anticoagulation properties. These grafts 
are easily prepared, immunologically compatible and 
appropriate for cell migration and growth and can be 
remolded into the neoartery in a minipig model.
Materials and methods
Preparation of autologous tissue conduits
The Teflon tubings (out diameter 3.9 mm) were tailored 
into 6 cm long segments, then immersed in 75% alcohol 
for sterilization. Miniature pigs (n = 8, female) weighing 
25–30 kg were injected intramuscularly with zolazepam 
(5  mg/kg), xylazine (2.25  mg/kg) and atropine (1  mg) 
for pre-anesthesia, the pigs were masked with isoflurane 
to induce sedation, endotracheal tube was positioned 
through the mouth, ventilate the animal with a mix-
ture of oxygen and nitrogen (1:2 v/v), using the follow-
ing ventilator settings: Pressure control mode: positive 
end-expiratory pressure (PEEP) 4 cm  H2O; peak inspira-
tory pressure 16–18 cm  H2O; breathing frequency 12–16 
times per minute; this should result in a tidal volume 
of ~ 10  ml/kg. general anesthesia was induced by means 
of intravenous administration of fentanyl (10 μg/kg/h) via 
the ear vein catheter.
After well anesthesia, pigs were placed at the animal 
experimental platform with dorsal position, the abdomi-
nal skin was prepared without hair, disinfected three 
times with 0.1% povidone iodine. A small horizontal 
incision about 3  cm was made by surgical knife, then a 
longitudinal subcutaneous pocket was formed by blunt 
dissection and the tubings were inserted in this pocket, 
and a total of 8 tubings were inserted through 4 small 
incisions for each pig. Pigs were then send back to cages 
with conventional feeding. After 4  weeks, tubings with 
tissue conduits formed around them were harvested, 
extracted the tubings away and cleaned of excess tissue, 
left the tissue conduits, then stored them in 4 °C PBS with 
1% penicillin and streptomycin for further proceeding. 
The pigs were kept alive for autologous implantation. All 
pigs received humane care and treatment in accordance 
with the ‘‘Guide for the Care and Use of Laboratory Ani-
mals in Huazhong University of Science and Technology’’.
Decellularization of autologous tissue conduits
The prepared tissue conduits were washed with PBS 
for 3 times, then they were decellularized by incubating 
them in a solution of 8 mM CHAPS, 1 M NaCl, 0.12 mM 
NaOH and 25 mM EDTA in d  H2O for 2 h on a stir plate 
at 37  °C, repeated for 5 times with refreshed decellu-
larization solution. After 5 circles, the grafts were then 
washed 3 times in PBS for 10 min on a stir plate. After 
the decellularization process, grafts were stored in 4  °C 
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PBS with 1% penicillin and streptomycin for further pro-
ceeding or testing.
DNA quantification
The total amount of DNA of non-decellalarized or decel-
lularized grafts was quantified using a DNA isolation 
kit for tissues. Briely, 40  mg wet weight samples were 
digested using a cell lysis buffer and Proteinase K fol-
lowed by a protein precipitation solution and centrifuga-
tion to remove the protein fraction. In order to isolate the 
DNA, the supernatant was added with isopentanol and 
ethanol and then centrifuged and rehydrated with a DNA 
rehydrating solution. Total DNA was finally quantified 
using a spectrophotometer at 260 nm.
Mechanical properties
Burst pressure
Burst pressure were measured by a customer designed 
flow system with the pressure transducer. 5  cm long 
grafts were attached to the flow system, PBS was injected 
into the flow system, and the pressure was increased in 
50 mmHg increments until the graft failed, generally by 
pinhole leak or rupture. Record the maximum pressure 
as the burst pressure.
Suture retention strength
This test is intended to determine the force necessary 
to pull a suture from the prosthesis or cause the wall 
of the prosthesis to fail. Suture strength was measured 
in accordance with the ANSI/AAMI/ISO 7198 stand-
ard. A 2  cm long graft was prepared, three 6-0 prolene 
sutures, separated by 120°, were inserted 2 mm from the 
end of the graft through one wall to form a half loop. The 
sutures were pulled at the rate of 50  mm/min using an 
SANS Electromechanical Universal Testing Machine (IS 
09001, SHENZHEN SANS TESTING MACHINE CO. 
LED), the three results were averaged for each sample.
Uniaxial traction testing
Grafts were cut into 5  mm long rings, measure and 
record the thickness and length of the rings in millim-
eters. Thread the specimen over the two pins subjected 
to SANS Electromechanical Universal Testing Machine. 
Samples were pre-loaded to 10% of failure strain prior to 
testing, stretch the specimen at a steady rate of 50 mm/
min until the break point was reached. Ultimate tensile 
strength (UTS) and ultimate strain were defined by the 
peak stress and maximum deformation withstood by the 
samples prior to failure.
Covalently linked with heparin
Heparin was covalently linked to decellularized tissue 
conduits by the crosslinks between succinimidyl esters 
on the heparin and amino functions on the collagen, 
while the succinimidyl esters was activated from Carbox-
ylic acid groups of heparin (Hep-COOH) by EDC and 
NHS. More detailly, heparinzation solution was consisted 
of solution A and solution B, where solution A was pre-
pared with EDC (40 mg/ml) and Sulfo-NHS (20 mg/ml) 
in MES buffer (0.05 M, PH = 5.5) over 12 h at room tem-
perature, solution B was prepared with heparin sodium 
(60 mg/ml) in MES buffer (0.05 M, PH = 5.5). Fresh hep-
arinization solution was prepared by mixing solution A 
and solution B together with volume ratio 1:1 at room 
temperature for 30 min, PH was adjusted to 7 with 1 M 
NaOH solution, then sterilized with 2  μm filter. Decel-
lularized grafts were immersed in freshly prepared hep-
arinization solution on a stir plate at room temperature 
for 5  h. After the heparinization procedure, grafts were 
washed with PBS.
The heparin-linked grafts were qualitative observed by 
toluidine blue staining. Briefly, 0.0005% toluidine blue 
solution was prepared in 0.01 M hydrochloric acid with 
0.2% (w/v) sodium chloride, heparin-linked grafts were 
incubated in the toluidine blue solution overnight, hepa-
rin free grafts incubated as control. The blue-purple color 
appeared on the grafts indicated that heparin was linked 
to grafts.
The heparin-linked grafts were tailored into 5 mm long 
segments, weighed them and dissolved them in 5  ml 
chloroform/acetone (1:1 v/v ratio), the solution was cen-
trifuged at 14,000g for 10 min, keep the precipitate, wash 
the precipitate with chloroform/acetone solution for 2 
times, the organic solvent was evaporated at room tem-
perature, leaving the heparin pellet extracted from the 
grafts. Next, immersed them in 8  ml toluidine blue/n-
hexane (1:1 v/v ratio) solution for 6  h, meanwhile, a 
series of standard heparin with known concentration was 
incubated in 8 ml toluidine blue/n-hexane (1:1 v/v ratio) 
solution for 6  h also. The absorbance of both samples 
and standard heparin solution were measured at 630 nm 
using a plate reader.
The heparin-linked grafts were incubated in PBS, 
shaken in a water bath at 37 °C for 12 h, then for qualita-
tive test as introduced above.
Implantation and explantation in porcine models
From 3 days before surgery, aspirin (5 mg/kg) and clopi-
dogrel (1  mg/kg) were given with one time each day. 
Aspirin and clopidogrel were continued daily till grafts 
explantation. After anesthetized by former methods, pigs 
were placed at the animal experimental platform  with 
dorsal position, mark one 10 cm line above the left com-
mon carotid artery (1.5 cm apart from median line). The 
ear margin venous channels were established to insure 
liquid injection. Strict aseptic conditions and techniques 
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were used for all procedures. The skin of the incision 
was cutted by surgical knife along the mark line, subcu-
taneous tissues were carefully dissected with an electric 
knife, superficial muscles were separated by blunt dis-
section, then cleidomastoid was well exposed. Along the 
gap between cleidomastoid and trachea, find the carotid 
sheath, the left common carotid artery was carefully 
dissected from the surrounding tissues by blunt dissec-
tion. Before clamping the artery, heparin (100  IU/kg) 
was administered intravenously, the artery was rinsed by 
glyceryl trinitrate to avoid angiospasm. The left common 
carotid artery was clamped with atraumatic vascular 
clamps (5.7 cm), approximate 5 cm long artery between 
the two clamps was dissected, tissue conduits (decel-
lularized and heparinized) were implanted using 6-0 
prolene as an end-to-end anastomosis to the common 
carotid artery, by interrupted suturation.. The animals 
were randomly divided into two groups, and the vas-
cular prostheses were retrieved when the animals were 
killed at 1 (n = 5) and 2 (n = 3) months after implantation. 
The patency was inspected by duplex ultrasound before 
explantation. Heparin (100  IU/kg) was administered 
intravenously, clamp the proximal and distal artery, the 
implanted grafts were removed from the left common 
carotid artery. The removed grafts were cross-segmented 
and washed with PBS, then fixed with formalin or stored 
at − 80 °C for further test.
Histological analysis
The native common carotid arteries, decellularized tissue 
conduits and post-implantation grafts were fixed in for-
malin and paraffin-embedded, 5 μm thick sections were 
cut using a microtome. Hematoxylin–eosin, Masson’s tri-
chrome, Verhoeff staining were employed for histological 
analysis. To identify endothelial cells and smooth mus-
cle cells, immunostaining was performed with antibody 
to Von Willebrand factor (abcam, ab6994) and alpha 
smooth muscle actin (abcam, ab7817).
Statistical analysis
The results of quantitative studies were expressed as the 
mean ± standard deviation, a standard t test was used to 
determine the significance of the difference between the 
2 means, and analyzed using a statistical analysis soft-
ware IMB SPSS Statistics 19. p < 0.05 was considered sta-
tistically significant.
Results
Preparation of autologous tissue conduits
Smooth and unmodified Teflon tubings with an external 
diameter of 3.9  mm was tailored into 6.0  cm long seg-
ments (Fig.  1A). They were subsequently immersed in 
75% alcohol solution for 30  min. The sterilized tubings 
were then inserted into the subcutaneous pocket on 
abdomen of miniature pigs (Fig.  1B). Four weeks after 
subcutaneous implantation, thick and autologous tissue 
conduits were formed around the tubings. They were eas-
ily harvested with little adhesion. Excess tissue was care-
fully removed and the tubing was extracted, leaving an 
autologous, smooth and thick tissue conduit that can be 
used as vascular graft (Fig. 1C, D).
Decellularization and heparinization analysis
The tissue conduit before decellularization was com-
posed of cells and collagen-rich extracellular matrix, the 
cells were supposed to fibroblast, no elastin was observed 
(Fig. 2A–C). After decellularization, the cellular compo-
nent was seldom observed, with a well reserved colla-
gen-rich extracellular matrix (Fig. 2D–F). DAPI staining 
showed the cellular component was well removed by 
CHAPS detergent (Data was not shown). There was a sig-
nificant difference in DNA content before and after decel-
lularization (0.011 ± 0.003  μg/mg vs 0.081 ± 0.010  μg/
mg, p < 0.05) (Fig.  2G). The average thickness of the 
non-decellularized, decellularized and native artery 
were 324.1 ± 57.4  μm (n = 6), 525.7 ± 119.8  μm (n = 6), 
637.4 ± 50.6  μm (n = 6) respectively, with no statistical 
difference in thickness between decellularized and native 
artery (p > 0.05) (Fig.  2H). Heparin was conjugated to 
decellularized tissue conduits by Sulfo-NHS/EDC. The 
average content of heparin that conjugated to tissue con-
duits was 8.2 ± 0.9 μg/mg, after a water bath at 37 °C for 
12  h. The tissue conduit color was still blue stained by 
toluidine compared with the tissue conduit prepared by 
the same procedure but without PBS treatment (Fig. 2I).
Mechanical analysis
Before decellularization, the burst pressure of the tissue 
conduit was 3696 ± 194  mmHg (n = 6), suture reten-
tion strength was 4.97 ± 0.55  N (n = 6), ultimate ten-
sile strength was 3.16 ± 0.30  MPa (n = 6) and ultimate 
strain was 24.33 ± 2.15% (n = 6). After decellulariza-
tion, the burst pressure of tissue conduit was decreased 
to 3157 ± 216  mmHg (n = 6), suture retention strength 
was decreased to 3.94 ± 0.46  N (n = 6), ultimate tensile 
strength was decreased to 2.41 ± 0.22 MPa (n = 6) while 
ultimate strain was increased to 30.63 ± 2.74% (n = 6). 
However, there were no statistically significant differ-
ences in mechanical properties between non-decel-
lularized and decellularized tissue conduits (p > 0.05) 
(Fig. 3a–d).
Surgical procedure
The diameter of tissue conduits matched with the carotid 
artery diameter (Fig.  4A), it was well anastomosed to 
common carotid artery as an interposition graft while 
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the blood flow in the graft was patent with obvious pulse 
(Fig. 4B). One and 2 months following implantation, the 
interposition grafts were patent with intact intima with 
no thrombus observed (Fig.  4C, D). 5 pigs were fol-
lowed up for 1 month with the Doppler ultrasound. The 
patency rate was 100% (5/5) with the average inner diam-
eter at 3.43 ± 0.05 mm (n = 5). Three pigs were followed 
up after 2 months with Doppler ultrasound. The patency 
rate was 67% (2/3) and the average inner diameter was 
2.32 ± 0.14 mm (n = 2). There were no significant differ-
ences for inner diameters between follow-up grafts at 1 
and 2 months.
Histology analysis after implantation
After implantation, cells migrated into the graft wall, with 
few elastin formed on the graft wall at the first month 
after implantation, but little remodeling was observed. 
2 months after implantation, there were increased num-
ber of cells that migrated into the graft walls with more 
mature wave-like elastin also observed in the graft wall 
(Fig.  5a–c). Immunofluorescence results showed that a 
confluent endothelial monolayer covering of the lumen, 
and a large number of alpha smooth muscle actin 
(α-SMA) positive cells were observed in the entire graft 
wall (Fig. 6A–D).
Discussion
Various types of natural and synthetic scaffolds with arte-
rial tissue cells or differentiated stem cells have recently 
attracted interest as potential small-diameter vascu-
lar grafts. L’heureux et al. employed tissue cells without 
synthetic materials to fabricate small-diameter vascular 
grafts which facilitated arteriovenous access in human 
adults for the first time [16]. They harvested autologous 
fibroblasts and endothelial cells from a small biopsy spec-
imen of skin and a superficial vein. Subsequently, tissue 
sheets were formed by cell culture in  vitro with autolo-
gous tissue engineering vascular grafts fabricated by self-
assemble technology with these tissue sheets. Niklason 
et al. engineered vascular grafts using human allogeneic 
or canine smooth muscle cells grown on a tubular poly-
glycolic acid scaffold in a bioreactor for about 8  weeks. 
After the degradation of the polyglycolic acid scaffold, 
cellular material was removed with detergents [17]. These 
two types of tissue engineering vascular grafts acquired 
great success in animal models as well as for humans 
who need hemodialysis. However, the manufacturing 
or pre-treatment process of these grafts is complicated, 
expensive, and time-consuming. In this study, we demon-
strated the totally autologous extracellular matrix-based 
grafts in small-diameter artery reconstruction, which 
Fig. 1 Preparation of an autologous tissue conduit after the implantation of a Teflon tubing in a minipig at 28 days. A Tailored Teflon tubing with 
external diameter 3.9 mm, 6.0 cm in length. B A Teflon tubing was implanted into the subcutaneous pocket on abdomen of a minipig through 
a small incision. C The tubular template covered with a capsule of living tissue was harvested with the minimally invasive techniques. D After 
trimming excess tissue and removing the Teflon tubing, an autologous connective tissue conduit was prepared
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were prepared by in vivo tissue engineering technology. It 
would be more suitable for clinical application because of 
it is totally immunologically compatible and a relatively 
convenient preparation process. As a candidate material 
for our in vivo tissue engineering, we focused our atten-
tion on its foreign body reaction in the host. For the sake 
of our designed objective, materials were selected that 
would induce only moderate foreign body reactions so 
that the fabricated foreign body granulomatous conduct 
would have appropriate thickness, mechanical properties 
and microstructure.
Studies have shown that, after embedded in the sub-
cutaneous pocket of host, different materials with dif-
ferent surface properties would bring different tissue 
regeneration process [18–20]. Silastic and silicone are 
two materials that had been used in in vivo tissue engi-
neering technology to fabricate small-diameter vascu-
lar grafts. They had adequate plasticity and were easily 
Fig. 2 Autologous tissue conduits before (A–C) and after (D–E) decellularization. H&E staining (A, D), Masson’s trichrome staining (B, E), Verhoeff’s 
staining (C, F). G The average wall thickness of the common carotid artery, non-decellularized and decellularized autologous tissue conduits. H 
DNA quantification of non-decellularized and decellularized autologous tissue conduits. I Qualitative (left) and stabilization (right) test of heparin by 
toluidine blue for the inner surface of the tissue conduit. Scale bar, 50 μm
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Fig. 3 Mechanical properties of non-decellularized and decellularized autologous tissue conduits. a Burst pressure, b Suture retention strength, c 
Ultimate tensile strength, d Ultimate strain
Fig. 4 Implantation and explantation of a decellularized autologous tissue conduit conjugated with heparin as a common carotid artery 
interposition graft. A The decellularized autologous tissue conduit anastomosed as an end-to-end bypass in the porcine carotid artery. B 
Immediately post implant. White arrows indicate the anastomotic sites. C The sample explanted at 1 month demonstrates the patent graft. D Gross 
appearance of the inner surface of the neoartery at 2 months after implantation
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obtained, but the grafts were poor in mechanical prop-
erties [21–23]. To fabricate autologous tissue conducts 
with appropriate mechanical properties, one type of 
complex co-polymer (PEOT/PBT) was adopted in a 
recent study [4]. The tissue grafts had relatively excellent 
performance in porcine model, but the fabrication of this 
compound required high technology and was very time 
consuming. In our previous study, 5 different materi-
als nylon, plexiglass, silicone, Teflon and polyvinyl chlo-
ride were fabricated into solid cylindrical tubes of the 
same size, and were then embedded in the subcutane-
ous pocket of rats for 4 weeks. Histology and mechani-
cal properties of the newly formed tissue conducts were 
evaluated. We found that the Teflon group had the best 
performance in histology and mechanical properties. 
In our miniature pig model, the burst pressure of tissue 
conduits induced by subcutaneously embedding with 
Teflon tube was 3696 ± 194 mmHg. It was strong enough 
to suffer the systemic pressure of pigs and even humans, 
in the in  vivo implantation study, no case of rupture or 
aneurysm formation was observed. Although proper-
ties of foreign body granulation tissue induced by dif-
ferent materials might be diverse, the component of this 
foreign body granulation tissue was relatively constant 
which was mainly composed of fibroblasts, small amount 
of macrophages, collagen I/IV and glycosaminoglycans, 
without elastin.
Decellularization technology is widely applied in tissue 
engineering. Generally, it can be achieved by physical, 
chemical or biologic-enzyme methods, two or three of 
them were always combined practically. Cells or cellular 
components were removed by this process, leaving the 
well reserved and polyporus extracellular matrix without 
immunogenicity and convenient for host cell migration 
and reconstruction. Also, decellularized tissue or organs 
could be preserved by lyophilization for extensive appli-
cations. CHAPS was a zwitterionic detergent used in the 
laboratory to  solubilize  biological macromolecules such 
as  proteins. The treated artery tissue had histologically 
normal collagen and elastin morphology. The collagen 
content appeared to remain similar to that of the native 
artery, however, the burst pressure of arterial tissue 
was significantly decreased after decellularization with 
CHAPS alone. To improve the mechanical properties, 
CHAPS was used in conjunction with hypertonic deter-
gents such as EDTA during our decellularization process. 
In our study, it can be seen that the cellular component 
was completely removed, no fracture was observed on 
decellularized tissue and there was a significant differ-
ence in DNA content before and after decellularization 
Fig. 5 Remodeling of grafts at 1, 2 months after implantation. H&E staining (a) of the grafts during the transition into a neoartery. Masson’s 
trichrome (b) and Verhoeff’s staining (c) show collagen (blue) and elastin (black). White arrows indicate elastin. Scale bar, 50 μm
Page 9 of 11Wang et al. J Transl Med           (2019) 17:24 
(Fig.  2G). More importantly, there were no significant 
difference in mechanical properties between non-decel-
lularized and decellularized tissue conduits (Fig. 3). The-
oretically, our decellularized tissue conduit was more 
polyporus. Therefore, it would be a more suitable micro-
environment for self-renewal of the vascular architecture 
than a non-decellularized tissue conduit.
To improve the anticoagulation properties of the tissue 
engineering vascular grafts, endothelial cell seeding and 
covalently linked with anticoagulation substance were 
two ways that have been widely experimented. As men-
tioned before, the main component of our decellularized 
autologous extracellular matrix-based graft was collagen; 
it was one kind of protein which was found to be suscep-
tible to thrombosis. It was proposed that the efficiency 
of an endothelial cell seeding was unreliable and time 
consuming. One study showed that the heparin-linked 
tissue engineering vascular graft had better anticoagu-
lation properties than the one without heparin in  vitro 
[24]. Another study showed that the heparin linked tis-
sue engineering vascular graft (PTFE) had better patency 
rate in an animal model [25]. In our study, heparin was 
covalently linked to decellularized autologous tissue con-
duct by Sulfo-NHS/EDC. It was hypothesized that the 
heparin would block the collagen on our decellularized 
conduits, thus preventing it from being exposed to blood. 
Besides, the covalently linked heparin would provide an 
attachment point for endothelial cells. It was reported 
that endothelialization was complete by 1 month follow-
ing grafting [26]. In order to guarantee that no thrombus 
would form, antiplatelet and anticoagulant drugs were 
employed, consequently, no thrombus was observed for 
at least 1 month.
Our vascular grafts used for carotid artery recon-
struction in miniature pig model had a 100% patency 
rate at 1 month post-grafting, with no thrombus forma-
tion, neointimal hyperplasia and aneurysms observed 
while cells migrated into the graft wall, with only a 
little remodeling observed. We found that more cells 
migrated into the implanted graft close to anastomo-
sis than the middle of graft. That means both circulat-
ing progenitor cells and transmural ingrowth of certain 
pericytes were involved in the cellularization process of 
artery reconstruction. To avoid complete tissue regen-
eration simply by transmural ingrowth of host cells, the 
graft length was predetermined to be 5  cm. Immuno-
fluorescence revealed the differentiation of some vWF, 
α-SMA positive cells on the graft close to anastomoses. 
Fig. 6 Smooth muscle cell remodeling and endothelialization of the autologous tissue conduits at 2 months after implantation. Nuclei are stained 
by DAPI (A). Double immunostaining for alpha smooth muscle actin and Von Willebrand factor (B–D). Scale bar, 50 μm. Lu lumen
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It was hard to say whether the vWF, α-SMA positive 
cells were differentiated from stem cells or a transmural 
ingrowth of mature cells. More interesting, some elas-
tin was formed in the graft wall at the first month after 
implantation. This process played an important role in 
artery reconstruction. However, it could not be realized 
in a bioreactor. After 2  months, the patency rate was 
67%, one pig was observed to have thrombus formation 
by ultrasound. After dissection, we found that the for-
mation of the thrombus was a consequence of anasto-
motic stenosis. There were more α-SMA positive cells 
migrated into the grafts wall with a confluent endothe-
lial monolayer covering of the lumen after 2  months. 
We therefore speculate that circulating progenitor cells 
would fall into the scaffold and induce in  situ recon-
struction. Meanwhile, transmural ingrowth of certain 
pericytes that guide vascular regeneration into the graft 
would occur more readily.
The limitations of our study are the lack of non-decel-
lularized and heparin free grafts in our vasotransplan-
tation model. We verified the feasibility of the project, 
with our graft showing good patency and in situ tissue 
regeneration, but whether decellularization and cova-
lently linked with heparin had more benefits was not 
confirmed yet. From other studies, we speculate that 
these two processes would bring great benefits for cell 
migration and anti-thrombosis. To resolve these limi-
tations, it would be necessary to implement a control 
group in the study for comparison.
Conclusions
In conclusion, our decellularized autologous extracel-
lular matrix-based vascular grafts showed good patency 
in a miniature pig model and good in situ cellularization 
and reconstruction, including relatively early endothe-
lialization and population with smooth muscle cells and 
excellent mechanical property performance. Our grafts 
had sufficient durability and patency to be used for small-
diameter artery reconstruction, particularly in peripheral 
arterial surgery, and might provide a wide variety of ther-
apeutic options in cardiovascular surgery.
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